| Determinants of aspirin resistance in patients with type 2 diabetes E Paven, JG Dillinger, CB dit Sollier, T Vidal-Trecan, N Berge, R Dautry, ... Diabetes & Metabolism 46 (5), 370-376, 2020 | 30 | 2020 |
| Elevated Brain Natriuretic Peptide and High Brachial Pulse Pressure in Patients With Diabetes JG Dillinger, C Patin, P Bonnin, T Vidal-Trecan, E Paven, JF Gautier, ... American Journal of Hypertension 35 (5), 414-422, 2022 | 7 | 2022 |
| Impact of sacubitril/valsartan on systolic heart failure: Right heart location and clustering analysis Y Bouali, E Galli, E Paven, C Laurin, H Arnaud, E Oger, E Donal Advances in Clinical and Experimental Medicine 31 (2), 109-119, 2022 | 7 | 2022 |
| One year prognostic value of B‐lines in dyspnoeic patients A Bidaut, A Hubert, M Charton, E Paven, C Leclercq, E Galli, E Donal ESC Heart Failure 8 (3), 1759-1766, 2021 | 7 | 2021 |
| Management of radiation-induced valvular heart disease due to Hodgkin’s Lymphoma in the modern era E Paven, C Cimadevilla, M Urena, MP Dilly, P Nataf, R Raffoul, D Himbert, ... EuroIntervention 13 (15), e1771-e1773, 2018 | 7 | 2018 |
| Could echocardiographic left atrial characterization have additive value for detecting risks of atrial arrhythmias and stroke in patients with hypertrophic cardiomyopathy? AA Wazzan, E Galli, M Lacout, E Paven, G L’official, F Schnell, E Oger, ... European Heart Journal-Cardiovascular Imaging 24 (5), 616-624, 2023 | 6 | 2023 |
| Controlled arterial reflow after ischemia induces better outcomes in the juvenile rat brain P Bonnin, J Pansiot, E Paven, M Eloi, S Renolleau, O Baud, PL Leger, ... Journal of Cerebral Blood Flow & Metabolism 37 (9), 3091-3096, 2017 | 3 | 2017 |
| Plasma Indoleamine 2, 3-dioxygenase is predictive of left ventricular remodeling after myocardial infarction M Saadi, N Vodovar, E Paven, M Sadoune, G Barnabas, G Desrumeaux, ... Archives of Cardiovascular Diseases Supplements 12 (1), 144, 2020 | 2 | 2020 |
| Determinants of aspirin loss of efficacy in type 2 diabetic patients E Paven, J Dillinger, CBD Sollier, T Vidal-Trecan, JM Launay, R Dautry, ... Archives of Cardiovascular Diseases Supplements 10 (1), 114-115, 2018 | 2 | 2018 |
| Management of radiation-induced valvular heart disease in the modern area E Paven, M Urena, C Cimadevilla, MP Dilly, L Lepage, C Verdonk, ... Archives of Cardiovascular Diseases Supplements 10 (1), 84, 2018 | 2 | 2018 |
| Constrictive epicarditis in adult-onset still’s disease E Charbonneau, E Donal, N Nessler, E Flecher, E Paven Acta Cardiologica 78 (4), 468-471, 2023 | 1 | 2023 |
| Haemodynamic evaluation: a key tool for heart failure management E Donal, E Galli, E Paven, LE Sade European Journal of Heart Failure 23 (5), 713-715, 2021 | 1 | 2021 |
| Combined exercise and imaging: key tool for clinical challenges E Donal, E Paven, E Galli Heart 106 (14), 1041-1042, 2020 | 1 | 2020 |
| What are the main determinants of an increase in bnp level in asymptomatic diabetic patients without known cardiac disease? C Patin, TV Trecan, JG Dillinger, E Paven, AC Solal, D Logeart, ... EUROPEAN HEART JOURNAL 40, 1453-1453, 2019 | 1 | 2019 |
| P5444 Plasma Indoleamine 2, 3-dioxygenase is highly predictive of cardiac remodeling after myocardial infarction N Vodovar, M Saadi, E Paven, M Sadoune, JJ Mercadier, JM Launay, ... European Heart Journal 40 (Supplement_1), ehz746. 0400, 2019 | 1 | 2019 |
| TGF-β inhibitor galunisertib combined with antiangiogenic therapies showed antitumor effects in vitro and in vivo in hepatocellular carcinoma (HCC) A Tijeras-Raballand, C Hobeika, M Martinet, L Astorgues-Xerri, E Paven, ... Cancer Research 78 (13_Supplement), 2944-2944, 2018 | 1 | 2018 |
| Abstract B144: LY3039478, a novel Notch inhibitor, potentiates the antitumor effects of sorafenib in hepatocellular carcinoma (HCC) A Tijeras-Raballand, C Hobeika, M Martinet, E Paven, P Bonin, C Eveno, ... Molecular Cancer Therapeutics 17 (1_Supplement), B144-B144, 2018 | 1 | 2018 |
| Evolution and prognostic value of deformations parameters and myocardial work in transthyretin amyloid cardiomyopathy J Antonelli, E Paven, G L’official, M Lacout, E Oger, E Donal Archives of Cardiovascular Diseases Supplements 15 (1), 41, 2023 | | 2023 |
| Could left myocardial work help us for best managing patient with a primary mitral regurgitation? A Neveu, S Aghezzaf, G L’official, E Paven, E Galli, A Coisne, E Oger, ... Archives of Cardiovascular Diseases Supplements 15 (1), 74, 2023 | | 2023 |
| Prevention of stroke and atrial arrhythmia consequences in hypertrophic cardiomyopathies: a clinical challenge that could be best managed by a better echocardiographic left … A Al Wazzan, E Galli, V Panis, E Paven, G L" official, F Schnell, E Oger, ... European Heart Journal-Cardiovascular Imaging 23 (Supplement_1), jeab289. 025, 2022 | | 2022 |
